Entries by aaron

Granules India gets Zero 483’s from USFDA for Unit V facility in AP

Telangana: Granules India has informed in a BSE filing that the Company’s Unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India gets Zero 483’s from U.S. Food and Drug Administration (USFDA). The inspection was held from 8th April 2024 to 12th April 2024. This audit was a Pre Approval Inspection (PAI) and cGMP audit for Active Pharmaceutical […]

USFDA concludes inspection of Lupin Dabhasa facility with no observations

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP Inspection of its API manufacturing facility located at Dabhasa, India. The inspection was conducted from April 8 to April 12, 2024 and concluded with no observations. “We are pleased to announce the successful completion […]

Neutrophil-to-lymphocyte ratio may predict potential complications among type 2 diabetes patients: Study

India: A recent study published in Cureus has shown the usefulness of neutrophil-to-lymphocyte ratio (NLR) in the management of type 2 diabetes mellitus (T2DM) and in predicting long-term complications. The researchers revealed the equivalent efficacy of NLR to glycated hemoglobin (HbA1c) in predicting glycemic control. They suggest that since diabetes affects different body organs, NLR […]

Salt substitution reduces cardiovascular mortality in the high-risk population

A recent comprehensive review highlights the potential health benefits of salt substitution for cardiovascular outcomes. This research found that replacing regular salt with substitutes could lead to a reduction in mortality and major cardiovascular events among the high-risk populations. The crucial findings were published in the Annals of Internal Medicine. The study synthesized data from 16 […]

Zerlasiran may prevent heart disease by lowering lipoprotein(a) concentrations: JAMA

A new study revealed that Zerlasiran is not just safe and tolerable but also effective in substantially reducing the levels of lipoprotein(a) [Lp(a)] which is a key factor in the development of atherosclerotic cardiovascular disease (ASCVD) and calcific aortic stenosis. The key findings of this study were published in the Journal of American Medical Association. […]

All permitted seats will be considered as recognised seats: NMC clarifies

New Delhi: While answering the Frequently Asked Questions (FAQs) regarding the Postgraduate Medical Education Regulations (PGMER) 2023, the National Medical Commission (NMC) recently clarified that once permitted, the concerned postgraduate medical course shall be considered as recognised and therefore, the “seats permitted will be considered as recognised seats for registration of the degree awarded.” Postgraduate Medical […]

86.9 per cent TB treatment success rate until Dec 2023: Sources

New Delhi: India has made tremendous progress in the elimination of Tuberculosis from the country, the treatment success rate surged to 86.9 per cent by December 2023, marking the highest rate in nine years, according to sources. Under the leadership of Prime Minister Narendra Modi, the Government of India is aggressively pursuing the elimination of TB […]